DOI:

Medicine in Europe: proudly forging our own unique identity

Patrick W. Serruys, Editor-in-Chief

Dear Colleagues,

We, European Interventionalists, are we self confident enough?

And what would it mean for us to claim this continent for our way of practising medicine, within our cultural contexts, using our own communication media?

Here at the Thorax Centre I am often approached by one of our fellows submitting a paper for internal assessment and review. My first question to them is where they intend to submit the paper, and their spontaneous first response is usually some American journal of cardiology. If the topic they are working on concerns an issue in intervention, I always suggest they consider an interventional journal of cardiology… even then, most of the time, they mention one of the American publications.

And here lies the crux of a problem that is reflected in many aspects of the European mindset: To reach a worldwide forum we believe we must imperatively publish in an American journal! The quality of American publications and American culture is not the question here, but the unquestioned assumption on our own part that this must be the best route to take. This is an assumption that we make at the expense of our own institutions, publications – the professional pride in what we are doing here. Europe is the centre for much clinical research and training. The educational structure that is now being put in place for our sub-specialty, as discussed in the EAPCI column, will be second to none, and underlines the strength of what we are doing. Remember, that the percutaneous intervention that we practice is a young discipline partially created in Europe itself by emblematic figures such as Zeitler, Grüntzig, Kaltenbach… and readership in this field is shared by many specialised journals such as: Catheterisation and Cardiovascular Interventions; International Journal of Cardiovascular Interventions; Journal of Interventional Cardiology; Journal of Invasive Cardiology.

In Europe, our own journal has recently published a whole series of innovative papers: first-in-man and breaking trials, as well as seminal consensus documents that clearly establish the level and quality of what we are accomplishing here.

But that negative response from my fellows - this lack of self confidence in our own European organs - undermines our capability to have a strong and vital European journal of cardiology.

Is it our role to convince the others, those who doubt?

I’m not sure of this, especially when the truth is so obvious. The truth of almost 15,000 EuroPCR attendees in each of the last three years. The truth that in a recent issue of an American interventional journal ten of the 12 papers were European, and of the other two, one was from Japan, and only one from the USA itself. I say, bring our own papers back home!

Back home to the community that we have constructed, and continue to construct for our specialty. The integration of our work with the ESC, EuroPCR and EAPCI. The validity of our European practice and education.

Perhaps you are thinking that it’s easy for me who has been publishing these last 20 or 30 years in American journals to suggest to a junior staff member, to come home and publish with us. And I am not saying that I don’t understand your reluctance to submit to a journal that has still not received its PubMed listing, but at the same time I assure you that our papers are noticed, that they are being read, online and in our print publication. Our papers are being heard, in meetings around the world, in classrooms and with the industry. And we will have our PubMed listing one day. And we are proud of what we have accomplished, and we are even more proud of what you – the young European specialists – are doing, and we ask you again, submit your work to us, come home and fully join the community that is truly your own.

Volume 3 Number 2
Aug 20, 2007
Volume 3 Number 2
View full issue


Key metrics

Suggested by Cory

Debate

10.4244/EIJ-E-25-00009 Jun 16, 2025
Guideline recommendations for QFR should be revisited: pros and cons
Fearon W and Biscaglia S

Flashlight

10.4244/EIJ-D-24-00795 Jun 16, 2025
Transcaval transcatheter aortic valve implantation via left-sided venous access
Doyle C and Casserly I

Letter to the editor

10.4244/EIJ-D-25-00325 Jun 16, 2025
Reply: Completeness or complexity? A nuanced reflection on multivessel revascularisation
Laudani C et al
free

Letter to the editor

10.4244/EIJ-D-25-00197 Jun 16, 2025
Letter: Completeness or complexity? A nuanced reflection on multivessel revascularisation
Sticchi A and Biondi-Zoccai G
free

Research Correspondence

10.4244/EIJ-D-24-01048 Jun 16, 2025
Next-day and 48-hour discharge following alternative access for transcatheter aortic valve implantation
Zendo Y et al
Trending articles
310.93

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
172.13

Focus article

10.4244/EIJY19M08_01 Jan 17, 2020
EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion – an update
Glikson M et al
free
91.35

State-of-the-Art Review

10.4244/EIJ-D-20-01296 Aug 27, 2021
Management of cardiogenic shock
Thiele H et al
free
76.25

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
56.65

Clinical research

10.4244/EIJ-D-20-01155 Oct 20, 2021
A deep learning algorithm for detecting acute myocardial infarction
Liu W et al
free
35

Original Research

10.4244/EIJ-D-25-00331 May 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved